High-Sensitivity Cardiac Troponin Can Be an Ally in the Fight Against COVID-19

Circulation. 2020 Jun 2;141(22):1733-1735. doi: 10.1161/CIRCULATIONAHA.120.047008. Epub 2020 Apr 6.

Authors

Andrew R Chapman¹, Anda Bularga¹, Nicholas L Mills^{1

2}

Affiliations

¹ British Heart Foundation Centre for Cardiovascular Science (A.R.C., A.B., N.L.M.), University of Edinburgh, United Kingdom.
² Usher Institute of Population Health Sciences and Informatics (N.L.M.), University of Edinburgh, United Kingdom.

PMID: 32251612
DOI: 10.1161/CIRCULATIONAHA.120.047008

No abstract available

Keywords: COVID-19; coronavirus; severe acute respiratory syndrome coronavirus 2.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Acute Kidney Injury / diagnosis
Acute Kidney Injury / etiology
Betacoronavirus / isolation & purification
COVID-19
Coronavirus Infections / complications
Coronavirus Infections / pathology*
Coronavirus Infections / virology
Fibrin Fibrinogen Degradation Products / analysis
Humans
Lymphocyte Count
Myocardial Infarction / diagnosis
Myocardial Infarction / etiology
Myocardium / metabolism*
Pandemics
Pneumonia, Viral / complications
Pneumonia, Viral / pathology*
Pneumonia, Viral / virology
Proportional Hazards Models
Respiratory Distress Syndrome / diagnosis
Respiratory Distress Syndrome / etiology
SARS-CoV-2
Troponin I / analysis*

Substances

Fibrin Fibrinogen Degradation Products
Troponin I
fibrin fragment D

Grants and funding